← Open Payments lookup

KRISTEN LOOMAN: Open Payments

NPI 1205400439 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$646 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $646

Food & beverage: $534Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$159
Otsuka America Pharmaceutical, Inc.5$116
Axsome Therapeutics, Inc.6$110
Corium, LLC3$72
E.R. Squibb & Sons, L.L.C.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
ABBVIE INC.2$34
Supernus Pharmaceuticals, Inc.1$21

Products named: REXULTI, Auvelity, Azstarys, COBENFY, UZEDY, TRINTELLIX, CAPLYTA, VRAYLAR.

Industry payments across MA — which companies pay providers there.